Effect of carbamazepine-beta-cyclodextrin inclusion complex on seizure-like events in an in vitro model of temporal lobe epilepsy

1 World Health Organization. Geneva: World Health Organization . 2023. Epilepsy fact sheet. Search in Google Scholar

2 Mohammadzadeh P, Nazarbaghi S. The prevalence of drug-resistant-epilepsy and its associated factors in patients with epilepsy. Clin Neurol Neurosurg . 2022;213:107086. Search in Google Scholar

3 Avanzini G, Franceschetti S. Mechanisms of Epileptogenesis. In: Simon Shorvon, Emilio Perucca, Jerome Engel, editors. The Treatment of Epilepsy. Fourth Edition. John Wiley & Sons; 2016. p. 38–51. Search in Google Scholar

4 Savjani KT, Gajjar AK, Savjani JK. Drug Solubility: Importance and Enhancement Techniques. ISRN Pharm. 2012 Jul 5;2012:1–10. Search in Google Scholar

5 Johannessen Landmark C, Johannessen SI, Tomson T. Host factors affecting antiepileptic drug delivery—Pharmacokinetic variability. Adv Drug Deliv Rev . 2012;64(10):896–910. Search in Google Scholar

6 Fattorusso A, Matricardi S, Mencaroni E, Dell’Isola GB, Di Cara G, Striano P, et al. The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies. Vol. 12, Frontiers in Neurology. Frontiers Media S.A.; 2021. Search in Google Scholar

7 Löscher W, Klitgaard H, Twyman RE, Schmidt D. New avenues for anti-epileptic drug discovery and development. Vol. 12, Nature Reviews Drug Discovery. 2013. p. 757–76. Search in Google Scholar

8 Simonato M, Brooks-Kayal AR, Engel J, Galanopoulou AS, Jensen FE, Moshé SL, et al. The challenge and promise of anti-epileptic therapy development in animal models. Lancet Neurol. 2014 Sep;13(9):949—960. Search in Google Scholar

9 Löscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma. Vol. 52, Epilepsia. 2011. p. 657–78. Search in Google Scholar

10 Campos G, Fortuna A, Falcão A, Alves G. In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy. Epilepsy Res . 2018;146:63–86. Search in Google Scholar

11 Burnham WM. Why are Complex Partial Seizures Intractable? In: Burnham W. McIntyre and Carlen PL and HPA, editor. Intractable Seizures: Diagnosis, Treatment, and Prevention. Boston, MA: Springer US; 2002. p. 107–10. Search in Google Scholar

12 Reddy DS, Kuruba R. Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions. Vol. 14, International Journal of Molecular Sciences. 2013. p. 18284–318. Search in Google Scholar

13 Albus K, Wahab A, Heinemann U. Standard antiepileptic drugs fail to block epileptiform activity in rat organotypic hippocampal slice cultures. Br J Pharmacol. 2008 Jun 14;154(3):709–24. Search in Google Scholar

14 Anderson WW, Lewis D V, Swartzwelder HS, Wilson WA. Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res. 1986;398:215–9. Search in Google Scholar

15 Heinemann U, Kann O, Schuchmann S. An Overview of In Vitro Seizure Models in Acute and Organotypic Slices. In: Models of Seizures and Epilepsy. 2006: 35–44. Search in Google Scholar

16 Bazhenov M, Timofeev I, Steriade M, Sejnowski TJ. Potassium Model for Slow (2-3 Hz) In Vivo Neocortical Paroxysmal Oscillations. J Neurophysiol. 2004;92(2):1116–32. Search in Google Scholar

17 Mody I, Lambert JDC, Heinemann U. Low Extracellular Magnesium Induces Epileptiform Activity and Spreading Depression in Rat Hippocampal Slices . Vol. 57, JOURNAL OF NEUROPHYSIOL~GY. 1987. Available from: www.physiology.org/journal/jn Search in Google Scholar

18 Johannessen SI, Gerna M, Bakke J, Strandjord RE, Morselli PL. CSF Concentrations and Serum Protein Binding of Carbamazepoine and Carbamazepine-10, 11-Epoxide in Epileptic Patients. Br J Clin Pharmacol. 1976;3(4):575–82. Search in Google Scholar

19 National Center for Biotechnology Information. 2024 [cited 2024 Jan 15]. PubChem Compound Summary for CID 2554, Carbamazepine. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Carbamazepine. Search in Google Scholar

20 Bonifácio MJ, Sheridan RD, Parada A, Cunha RA, Patmore L, Soares-Da-Silva P. Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: Comparison with carbamazepine. Epilepsia. 2001;42(5):600–8. Search in Google Scholar

21 Barzegar-Jalali M, Nayebi AM, Valizadeh H, Hanaee J, Barzegar-Jalali A, Adibkia K, et al. Evaluation of in vitro-in vivo correlation and anticonvulsive effect of carbamazepine after cogrinding with microcrystalline cellulose. Vol. 9, J Pharm Pharmaceut Sci (www.cspsCanada.org). 2006. Search in Google Scholar

22 Kumar R, Siril PF. Ultrafine carbamazepine nanoparticles with enhanced water solubility and rate of dissolution. RSC Adv. 2014;4(89):48101–8. Search in Google Scholar

23 Qushawy M, Prabahar K, Abd-Alhaseeb M, Swidan S, Nasr A. Preparation and evaluation of carbamazepine solid lipid nanoparticle for alleviating seizure activity in pentylenetetrazole-kindled mice. Molecules. 2019;24(21):3971. Search in Google Scholar

24 Scioli Montoto S, Sbaraglini ML, Talevi A, Couyoupetrou M, Di Ianni M, Pesce GO, et al. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 2018 Jul 1;167:73–81. Search in Google Scholar

25 Frijlink HW, Visser J, Hefting NR, Oosting R, Meijer DKF, Lerk CF. The Pharmacokinetics of P-Cyclodextrin and Hydroxypropyl-JJ-cyclodextrin in the Rat. Vol. 7, Pharmaceutical Research. 1990. Search in Google Scholar

26 Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev. 1999;36(1):125–41. Search in Google Scholar

27 Koester LS, Bertuol JB, Groch KR, Xavier CR, Moellerke R, Mayorga P, et al. Bioavailability of carbamazepine:β-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets. Eur J Pharm Sci. 2004;22(2):201–7. Search in Google Scholar

28 Veszelka S, Mészáros M, Porkoláb G, Rusznyák Á, Réti-Nagy KS, Deli MA, et al. Effects of Hydroxypropyl-Beta-Cyclodextrin on Cultured Brain Endothelial Cells. Molecules. 2022 Nov 1;27(22):7738. Search in Google Scholar

29 Pytel M, Mercik K, Mozrzymas JW. Interaction between cyclodextrin and neuronal membrane results in modulation of GABA A receptor conformational transitions. Br J Pharmacol. 2006 Jun 8;148(4):413–22. Search in Google Scholar

30 Zhang ZJ, Koifman J, Shin DS, Ye H, Florez CM, Zhang L, et al. Transition to seizure: Ictal discharge is preceded by exhausted presynaptic GABA release in the hippocampal CA3 region. Journal of Neuroscience. 2012;32(7): 2499–2512. Search in Google Scholar

31 Wahab A, Albus K, Gabriel S, Heinemann U. In search of models of pharmacoresistant epilepsy. Epilepsia. 2010;51(s3):154–9. Search in Google Scholar

32 Quilichini PP, Diabira D, Chiron C, Milh M, Ben-Ari Y, Gozlan H. Effects of Antiepileptic Drugs on Refractory Seizures in the Intact Immature Corticohippocampal Formation In Vitro. Epilepsia. 2003;44(11):1365–74. Search in Google Scholar

33 D’Antuono M, Köhling R, Ricalzone S, Gotman J, Biagini G, Avoli M. Antiepileptic drugs abolish ictal but not interictal epileptiform discharges in vitro. Epilepsia. 2010;51(3):423–31. Search in Google Scholar

34 Gáll Z, Orbán-Kis K, Szilágyi T. Differential effects of sodium channel blockers on in vitro induced epileptiform activities. Arch Pharm Res. 2017 Jan 1;40(1):112–21. Search in Google Scholar

35 Rouaz K, Chiclana-Rodríguez B, Nardi-Ricart A, Suñé-Pou M, Mercadé-Frutos D, Suñé-Negre JM, et al. Excipients in the Paediatric Population: A Review. Pharmaceutics. 2021;13(3):387. Search in Google Scholar

36 Ahmed A. Does polyethylene glycol, used as an excipient at mRNA-based (Moderna, Pfizer) vaccines, cause an increase in the frequency of epilepsy in PWE? 2022. Search in Google Scholar